Literature DB >> 11518787

Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients.

Angela Yee Moon Wang1, Jean Woo1, Mei Wang1, Mandy Man Mei Sea1, Ricky Ip1, Philip Kam Tao Li1, Siu Fai Lui1, John Elsby Sanderson1.   

Abstract

Cardiac valve calcification (VC) has long been regarded as a consequence of aging and abnormal calcium-phosphate metabolism in uremic patients. In view of the recent recognition of association among inflammation, malnutrition, and atherosclerosis, the possible role of inflammation and malnutrition in VC was investigated. Inflammatory markers (including C-reactive protein [CRP], fibrinogen, and basal metabolic rate) and nutritional status (assessed using serum albumin, subjective global nutrition assessment, and handgrip strength) were examined, in addition to calcium phosphate parameters and other traditional cardiovascular risk factors, including gender, smoking habits, BP, and lipid profile, in relation to VC in 137 patients who were on continuous ambulatory peritoneal dialysis. Compared with patients with no VC, patients with VC not only were older (60 [10] versus 54 [12] yr; P = 0.005), had higher plasma phosphate (1.89 [0.52] versus 1.64 [0.41] mmol/L; P = 0.003), and had higher parathyroid hormone (83 [40, 145] versus 38 [16, 71] pmol/L; P = 0.001) but also had higher CRP (4.5 [0.1, 13.4] versus 0.2 [0.1, 4.4] mg/L; P = 0.004), had higher fibrinogen (6.6 [1.9] versus 5.7 [1.3] g/L; P = 0.002), and had lower serum albumin (26 [4] versus 29 [3] g/L; P = 0004). Twenty-three percent of patients with VC versus 17% of patients with no VC were moderately to severely malnourished according to subjective global nutrition assessment (P = 0.05). Even after adjustment for patients' age, duration of continuous ambulatory peritoneal dialysis, diabetes, and calcium x phosphate product, cardiac VC remained strongly associated with CRP (odds ratio, 1.05; P = 0.026) and albumin (odds ratio, 0.85; P = 0.01). The data suggest that VC not only is a passive degenerative process but also involves active inflammation, similar to that seen in atherosclerosis. The presence of uncontrolled hyperphosphatemia and hyperparathyroidism further accelerates the progression of calcification. The data also indicate that VC and atherosclerosis should be considered as associated syndromes, sharing similar pathogenic mechanisms, namely active inflammation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11518787     DOI: 10.1681/ASN.V1291927

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  38 in total

1.  Cardiovascular risk factors in patients with aortic stenosis predict prevalence of coronary artery disease but not of aortic stenosis: an angiographic pair matched case-control study.

Authors:  J R Ortlepp; F Schmitz; T Bozoglu; P Hanrath; R Hoffmann
Journal:  Heart       Date:  2003-09       Impact factor: 5.994

2.  Persistently low intact parathyroid hormone levels predict a progression of aortic arch calcification in incident hemodialysis patients.

Authors:  Harin Rhee; Sang Heon Song; Ihm Soo Kwak; Soo Bong Lee; Dong Won Lee; Eun Young Seong; Il Young Kim
Journal:  Clin Exp Nephrol       Date:  2012-01-05       Impact factor: 2.801

3.  The standard deviation of extracellular water/intracellular water is associated with all-cause mortality and technique failure in peritoneal dialysis patients.

Authors:  Jun-Ping Tian; Hong Wang; Feng-He Du; Tao Wang
Journal:  Int Urol Nephrol       Date:  2016-07-20       Impact factor: 2.370

Review 4.  Uremic encephalopathy in patients undergoing assisted peritoneal dialysis: a case series and literature review.

Authors:  Akane Yanai; Kiyotaka Uchiyama; Yoshitaka Ishibashi
Journal:  CEN Case Rep       Date:  2019-06-08

5.  Relationship between cardiac calcification and left ventricular hypertrophy in patients with chronic kidney disease at hemodialysis initiation.

Authors:  Ken Kitamura; Hideki Fujii; Kentaro Nakai; Keiji Kono; Shunsuke Goto; Tatsuya Nishii; Atsushi Kono; Shinichi Nishi
Journal:  Heart Vessels       Date:  2017-03-21       Impact factor: 2.037

Review 6.  Cardiac imaging in patients with chronic kidney disease.

Authors:  Diana Y Y Chiu; Darren Green; Nik Abidin; Smeeta Sinha; Philip A Kalra
Journal:  Nat Rev Nephrol       Date:  2015-01-06       Impact factor: 28.314

7.  Frequent hemodialysis with NxStage system in pediatric patients receiving maintenance hemodialysis.

Authors:  Stuart L Goldstein; Douglas M Silverstein; Jocelyn C Leung; Daniel I Feig; Beth Soletsky; Cathy Knight; Bradley A Warady
Journal:  Pediatr Nephrol       Date:  2007-11-08       Impact factor: 3.714

8.  Progression of coronary calcification in pediatric chronic kidney disease stage 5.

Authors:  Mahmut Civilibal; Salim Caliskan; Sebuh Kurugoglu; Cengiz Candan; Nur Canpolat; Lale Sever; Ozgur Kasapcopur; Nil Arisoy
Journal:  Pediatr Nephrol       Date:  2008-11-04       Impact factor: 3.714

9.  Higher ambulatory blood pressure is associated with aortic valve calcification in the elderly: a population-based study.

Authors:  Shinichi Iwata; Cesare Russo; Zhezhen Jin; Joseph E Schwartz; Shunichi Homma; Mitchell S V Elkind; Tatjana Rundek; Ralph L Sacco; Marco R Di Tullio
Journal:  Hypertension       Date:  2012-11-12       Impact factor: 10.190

10.  Is valvular calcification a part of the missing link between residual kidney function and cardiac hypertrophy in peritoneal dialysis patients?

Authors:  Angela Yee-Moon Wang; Christopher Wai-Kei Lam; Mei Wang; Iris Hiu-Shuen Chan; Siu-Fai Lui; John E Sanderson
Journal:  Clin J Am Soc Nephrol       Date:  2009-08-27       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.